Digital Gold. Digital Oil. Digital Infrastructure.
Bitcoin and Ethereum had their turn. Now a NASDAQ-listed firm is scaling BNB, which fuels 290M users and pays yield.
| Open | 63.00 | Prev Close | 62.88 |
| High | 65.30 | Low | 62.93 |
| Volume | 10,146,368 | Volume (Avg) | 3,630 |
| 52 Week High | 65.30 | 52 Week Low | 40.74 |
| Market Cap | 26.7B | PE Ratio | 12.85 |
General
| Name | Fox Corporation |
| Ticker | FOXA |
| Exchange | NASDAQ |
| Sector | Communication Services |
| Industry | Entertainment |
| Currency | USD |
| Country | USA |
| Fiscal Year End | June |
| Full Time Employees | 10,400 |
About Fox Corporation
Fox Corporation operates as a news, sports, and entertainment company in the United States. It operates in four segments: Cable Network Programming, Television, Credible, and The FOX Studio Lot. The Cable Network Programming segment produces and licenses news and sports content for distribution through traditional cable television systems, direct broadcast satellite operators, telecommunication companies, virtual multi-channel video programming distributors, and other digital platforms. Its Television segment produces, acquires, markets, and distributes programming through the FOX broadcast network, advertising-supported video-on-demand service Tubi, and operates full power broadcast television stations, including duopolies and other digital platforms. This segment also produces content for third parties. The Credible segment engages in the consumer finance marketplace. Its FOX Studio Lot segment provides television and film production services along with office space, studio operation services, and all operations of the facility. Fox Corporation was incorporated in 2018 and is headquartered in New York, New York.
Highlights
| Analyst Target | 61.84 |
| Market Cap | 26,706,300,000 |
| PE Ratio | 12.85 |
| PEG Ratio | 1.16 |
| EBITDA | 3,523,000,064 |
Valuation
| Trailing PE | 12.45 |
| Forward PE | 14.88 |
| Price/Sales (Trailing 12 Mt.) | 1.59 |
| Price/Book (Most Recent Quarter) | 2.28 |
Technicals
| Beta | 0.54 |
| 52 Week High | 65.30 |
| 52 Week Low | 40.74 |
| 50 Day Average | 7.86% |
| 200 Day Average | 16.49% |
Dividend
Fox Corporation pays out a dividend of $0.56 per share, with a dividend yield of 0.89%.
FOXA's last dividend payment was made to shareholders on September 24, 2025.
They pay out 11.00% of their earnings out as a dividend.
Recent Dividends
| Sep 24, 2025 | $0.28 |
| Mar 26, 2025 | $0.27 |
| Sep 25, 2024 | $0.27 |
| Mar 26, 2024 | $0.26 |
Helen Mirren opens Stella McCartney’s activist, cruelty-free Paris runway
PARIS (AP) — Inside the Centre Pompidou, opened ’s Paris Fashion Week show with a spoken rendition of ’ “Come Together.” Less performance than manifesto, it set the tone for a Tuesday night collection framed around humanity, animals and Mother Earth.
Senate Democrats Reject Funding Bill, Increasing Chances Of Government Shutdown By Oct. 1
Senate Democrats have rejected a stopgap spending bill passed earlier Friday by the House. This result has put Washington on the brink of a potential government shutdown, which could take place on Oct. 1.
The First Public Cash-Flowing Digital Treasury - Ad
Unlike Bitcoin vaults, this NASDAQ-listed company earns yield through BNB staking and nodes. $368M already deployed, still overlooked.
A robot programmed to act like a 7-year-old girl works to combat fear and loneliness in hospitals
Days after Meagan Brazil-Sheehan’s 6-year-old son was diagnosed with leukemia, they were walking down the halls of UMass Memorial Children’s Medical Center when they ran into Robin the Robot.
Trump Halts US Steel Plant Closure Using 'Golden Share' Authority: Report
President Trump has exercised his administration's "golden share" authority to prevent the shutdown of a US Steel plant in Illinois.
Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad
This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.
Oracle Stock Is Rallying To Start The Week: What's Driving The Momentum?
Oracle Corporation (NASDAQ: ORCL) shares are trading higher and trending on Monday. Here's a look at what's going on.
Pilgrims turn Spain's Santiago de Compostela into the world's latest overtourism flashpoint
SANTIAGO DE COMPOSTELA, Spain (AP) — While some Barcelona residents sought to repel a tsunami of tourists , a neighborhood association in Santiago de Compostela opted for a friendlier approach: a guide to good manners for visitors to their town, the endpoint of the Catholic world's most famous pilgrimage.
FDA Approval Could Send This Stock Soaring - Ad
Whenever the FDA approves a new drug... Timely investors could see 300-400% returns... ChemoCentryx soared 281% in the year after it won FDA approval... Immunogen jumped 449% in the two years after it won FDA approval... Even Krystal Biotech rose 242% when it looked like it would win FDA approval, which it did.
Asian benchmarks are mixed after Wall Street edges down from record highs
TOKYO (AP) — Asian shares traded mixed Wednesday after U.S. stocks edged down from record highs and as market focus turned to expectations for the Federal Reserve's .
Trump's $17 Trillion New Investments Claim 'Clearly' Not True, Says Peter Schiff: GDP Growth Would 'Explode by Roughly 50%' If Factual
Economist Peter Schiff is calling out President Donald Trump's claims regarding $17 trillion in new investments flowing into the U.S. economy.
The Next Evolution in Public Treasuries - Ad
MicroStrategy proved the model with BTC. Now a NASDAQ-listed firm is running it with BNB, yield, and 290M users. $368M locked in.
AquaBounty Technologies Stock Explodes Over 98% After Hours: Here's Why
AquaBounty Technologies saw a massive 98.25% surge in after-hours trading to $2.26, following confirmation that it had met NASDAQ's minimum bid price requirement, resolving its earlier delisting risk.
Trump Makes Chinese Stocks Great Again — Until Someone Mentions Tariffs
President Donald Trump's recent optimistic remarks on negotiations with China have given a boost to U.S.-listed Chinese stocks.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
Ethereum Co-Founder Vitalik Buterin Responds to Security Concerns Over OpenAI's ChatGPT
Ethereum co-founder Vitalik Buterin has voiced his concerns over potential security risks associated with OpenAI's ChatGPT, which could lead to the leakage of personal user data.
Ford to drop up to 1,000 jobs at German plant as demand for electric cars in Europe lags forecasts
FRANKFURT, Germany (AP) — Ford Motor Co. said Tuesday it would cut up to 1,000 jobs at its electric auto plant in Cologne, Germany due to lower than expected demand for battery-powered cars.
We've Seen This Before... and It Didn't End Well - Ad
Strange events are unfolding in the global financial system. A monetary reset dubbed the "Mar-a-Lago Accord" is quietly in motion, and the financial elite are already taking protective action. If history is any guide, you could lose up to 40% of your wealth in the next two years. Move your money before it's too late.
Canada's Carney heads to Mexico to discuss trade before a review of their US trade deal
TORONTO (AP) — Canadian Prime Minister Mark Carney heads to Mexico on Thursday in an effort to diversify trade as America’s neighbors brace for a review of the free trade deal with United States.
Trump Links Sanctions On Russia To NATO Unity, Calls Out Hungary And Slovakia Over Oil Purchases
Trump stated that sanctions on Russia would only be imposed if all NATO countries agree to identical measures and halt Russian oil purchases.
Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad
A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.
Republicans unveil a bill to fund the government through Nov. 21. Democrats call it partisan
WASHINGTON (AP) — House Republicans unveiled Tuesday a stopgap spending bill that would keep federal agencies funded through Nov. 21, daring Democrats to block it knowing that the fallout would likely be a partial government shutdown that would begin Oct. 1, the start of the new budget year.
Novo Nordisk, maker of obesity drug Wegovy, to cut 9,000 jobs to sharpen focus, meet competition
FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 of them in Denmark, in order to strengthen the company's focus on growth opportunities in obesity and diabetes medications.
Elon's $25 Trillion Confession - Ad
Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.
Hillary Clinton Says Trump Administration Is 'Going Great' For The President, Dogecoin Rallies 20%, Silver Token Tops Bitcoin — This Week In Crypto
The past week has been a rollercoaster ride in the world of finance and politics. From silver-backed cryptocurrencies outperforming Bitcoin (CRYPTO: BTC) to Hillary Clinton’s accusations of crypto corruption against the Trump administration, there’s been no shortage of headlines.
Charlie Kirk Raised $85 Million Last Year — Widow Vows to Continue His Work
The assassination of Turning Point USA founder Charlie Kirk at a Utah Valley University event on September 10 has cast a shadow of uncertainty over the future of his political and business ventures.
New Biotech Offering Targets $426B Rare Disease Market - Ad
The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.
Bitcoin, Ethereum, Dogecoin Consolidate As XRP Tries To Push Higher
Cryptocurrency markets are trading sideways on Tuesday as investors position ahead of the Federal Reserve's interest rate decision.
Family says a man who died after going on a Universal roller coaster never let wheelchair stop him
ORLANDO, Fla. (AP) — A 32-year-old man who from blunt impact injuries after going on a roller coaster at Universal Orlando Resort’s newest park used a wheelchair. But his family said it never stopped his unwavering spirit.
Digital Gold. Digital Oil. Digital Infrastructure. - Ad
Bitcoin and Ethereum had their turn. Now a NASDAQ-listed firm is scaling BNB, which fuels 290M users and pays yield.
Europe's Ryder Cup team uses VR headsets to prepare for noise and insults at Bethpage Black
VIRGINIA WATER, England (AP) — Whatever heckling European players might face at the Ryder Cup in New York could be what they already have heard before, all because of virtual reality headsets that Rory McIlroy says can be adjusted to hear the harshest abuse.
Cracker Barrel, D-Wave Quantum, IonQ, Krispy Kreme And Broadcom: Why These 5 Stocks Are On Investors' Radars Today
On Wednesday, U.S. stocks closed mixed as the Dow Jones Industrial Average advanced 0.6% to 46,018.32.
The First Public Cash-Flowing Digital Treasury - Ad
Unlike Bitcoin vaults, this NASDAQ-listed company earns yield through BNB staking and nodes. $368M already deployed, still overlooked.
Trump's H-1B Visa Plan Stuns Big Tech, White House Says $100,000 Fee Is One-Time Only
The White House clarified that the $100,000 H-1B visa fee is a one-time charge, not an annual fee, amid confusion among major tech companies.
US orders Delta and Aeromexico to dissolve their partnership over fairness concerns in Mexico
U.S. Transportation Secretary Sean Duffy is following through on to force Delta and Aeromexico to dissolve their longtime partnership because of his concerns that Mexico isn't being fair to U.S. airlines.
Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad
This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.
Elon Musk Back Atop Billionaires List, Tesla CEO Almost Recovers Lost Wealth Since Joining Hands With Trump
Elon Musk almost recovers wealth lost since aligning with Trump for 2024 election; now richest person thanks to surging Tesla stocks.
‘Race against time’ to remove rubble after recent earthquake in Afghanistan’s east, says UN
The United Nations says aid workers are still in a “race against time” to remove rubble and rebuild after the eastern Afghanistan last month, killing at least 2,200 people and cutting off remote areas.
FDA Approval Could Send This Stock Soaring - Ad
Whenever the FDA approves a new drug... Timely investors could see 300-400% returns... ChemoCentryx soared 281% in the year after it won FDA approval... Immunogen jumped 449% in the two years after it won FDA approval... Even Krystal Biotech rose 242% when it looked like it would win FDA approval, which it did.
Gemini Upsizes IPO To Raise $425 Million, Winklevoss Twins-Founded Crypto Exchange Targets $3 Billion Valuation
Cryptocurrency exchange Gemini raised $425 million in an initial public offering, pricing its shares above the expected range, according to an announcement made late Thursday.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.